Insulin signaling to the glomerular podocyte is critical for normal kidney function

Cell Metabolism

Volumn 12, Issue 4, 2010, Pages 329-340

  Welsh, Gavin I ^a   Hale, Lorna J ^a   Eremina, Vera ^b   Jeansson, Marie ^b   Maezawa, Yoshiro ^b   Lennon, Rachel ^a   Pons, Deborah A ^a   Owen, Rachel J ^a   Satchell, Simon C ^a   Miles, Mervyn J ^a   Caunt, Christopher J ^a   McArdle, Craig A ^a   Pavenstädt, Hermann ^c   Tavaré, Jeremy M ^a   Herzenberg, Andrew M ^d   Kahn, C Ronald ^e   Mathieson, Peter W ^a   Quaggin, Susan E ^b   Saleem, Moin A ^a   Coward, Richard J M ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; KIDNEY FUNCTION; MORPHOLOGY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL;

ANIMALS; DIABETIC NEPHROPATHIES; INSULIN; KIDNEY; KIDNEY GLOMERULUS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PODOCYTES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 77957657608     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.08.015     Document Type: Article

References (51)

1. D. Accili, J. Drago, E.J. Lee, M.D. Johnson, M.H. Cool, P. Salvatore, L.D. Asico, P.A. José, S.I. Taylor, and H. Westphal Early neonatal death in mice homozygous for a null allele of the insulin receptor gene Nat. Genet. 12 1996 106 109
2. K.O. Alsaad, and A.M. Herzenberg Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update J. Clin. Pathol. 60 2007 18 26
3. A.R. Andersen, J.S. Christiansen, J.K. Andersen, S. Kreiner, and T. Deckert Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study Diabetologia 25 1983 496 501
4. S.B. Biddinger, and C.R. Kahn From mice to men: insights into the insulin resistance syndromes Annu. Rev. Physiol. 68 2006 123 158
5. S.F. Bjørn, H.J. Bangstad, K.F. Hanssen, G. Nyberg, J.D. Walker, G.C. Viberti, and R. Osterby Glomerular epithelial foot processes and filtration slits in IDDM patients Diabetologia 38 1995 1197 1204
6. E.J. Brown, J.S. Schlöndorff, D.J. Becker, H. Tsukaguchi, S.J. Tonna, A.L. Uscinski, H.N. Higgs, J.M. Henderson, and M.R. Pollak Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis Nat. Genet. 42 2010 72 76
7. J.C. Brüning, M.D. Michael, J.N. Winnay, T. Hayashi, D. Hörsch, D. Accili, L.J. Goodyear, and C.R. Kahn A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance Mol. Cell 2 1998 559 569
8. C.J. Caunt, C.A. Rivers, B.L. Conway-Campbell, M.R. Norman, and C.A. McArdle Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases J. Biol. Chem. 283 2008 6241 6252
9. S.H. Chiang, C.A. Baumann, M. Kanzaki, D.C. Thurmond, R.T. Watson, C.L. Neudauer, I.G. Macara, J.E. Pessin, and A.R. Saltiel Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10 Nature 410 2001 944 948
10. R.J. Coward, G.I. Welsh, J. Yang, C. Tasman, R. Lennon, A. Koziell, S. Satchell, G.D. Holman, D. Kerjaschki, and J.M. Tavaré The human glomerular podocyte is a novel target for insulin action Diabetes 54 2005 3095 3102
11. R.J. Coward, G.I. Welsh, A. Koziell, S. Hussain, R. Lennon, L. Ni, J.M. Tavaré, P.W. Mathieson, and M.A. Saleem Nephrin is critical for the action of insulin on human glomerular podocytes Diabetes 56 2007 1127 1135
12. S. Cui, C. Li, M. Ema, J. Weinstein, and S.E. Quaggin Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockout mice J. Am. Soc. Nephrol. 16 2005 3247 3255
13. M. Ding, S. Cui, C. Li, S. Jothy, V. Haase, B.M. Steer, P.A. Marsden, J. Pippin, S. Shankland, and M.P. Rastaldi Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice Nat. Med. 12 2006 1081 1087
14. V. Eremina, M. Sood, J. Haigh, A. Nagy, G. Lajoie, N. Ferrara, H.P. Gerber, Y. Kikkawa, J.H. Miner, and S.E. Quaggin Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases J. Clin. Invest. 111 2003 707 716
15. S.Y. Gao, C.Y. Li, T. Shimokawa, T. Terashita, S. Matsuda, E. Yaoita, and N. Kobayashi Rho-family small GTPases are involved in forskolin-induced cell-cell contact formation of renal glomerular podocytes in vitro Cell Tissue Res. 328 2007 391 400
16. S.B. Gurley, S.E. Clare, K.P. Snow, A. Hu, T.W. Meyer, and T.M. Coffman Impact of genetic background on nephropathy in diabetic mice Am. J. Physiol. Renal Physiol. 290 2006 F214 F222
17. S. Hadjadj, F. Péan, Y. Gallois, P. Passa, R. Aubert, L. Weekers, V. Rigalleau, B. Bauduceau, A. Bekherraz, R. Roussel Genesis France-Belgium Study Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study Diabetes Care 27 2004 2661 2668
18. K. Isshiki, M. Haneda, D. Koya, S. Maeda, T. Sugimoto, and R. Kikkawa Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats Diabetes 49 2000 1022 1032
19. N. Kobayashi, S.Y. Gao, J. Chen, K. Saito, K. Miyawaki, C.Y. Li, L. Pan, S. Saito, T. Terashita, and S. Matsuda Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons? Anat. Sci. Int. 79 2004 1 10
20. R.N. Kulkarni, K. Almind, H.J. Goren, J.N. Winnay, K. Ueki, T. Okada, and C.R. Kahn Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice Diabetes 52 2003 1528 1534
21. P. Kurtzhals, L. Schäffer, A. Sørensen, C. Kristensen, I. Jonassen, C. Schmid, and T. Trüb Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use Diabetes 49 2000 999 1005
22. P.J. Lavin, R. Gbadegesin, T.V. Damodaran, and M.P. Winn Therapeutic targets in focal and segmental glomerulosclerosis Curr. Opin. Nephrol. Hypertens. 17 2008 386 392
23. R. Lennon, A. Singh, G.I. Welsh, R.J. Coward, S. Satchell, L. Ni, P.W. Mathieson, W.W. Bakker, and M.A. Saleem Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes J. Am. Soc. Nephrol. 19 2008 2140 2149
24. A.S. Maddox, and K. Burridge RhoA is required for cortical retraction and rigidity during mitotic cell rounding J. Cell Biol. 160 2003 255 265
25. S.B. Nicholas, Y. Kawano, S. Wakino, A.R. Collins, and W.A. Hsueh Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells Hypertension 37 2001 722 727
26. T. Nishikawa, D. Edelstein, and M. Brownlee The missing link: a single unifying mechanism for diabetic complications Kidney Int. Suppl. 77 2000 S26 S30
27. C.D. Nobes, and A. Hall Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia Cell 81 1995 53 62
28. A. Novak, C. Guo, W. Yang, A. Nagy, and C.G. Lobe Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision Genesis 28 2000 147 155
29. T.J. Orchard, Y.F. Chang, R.E. Ferrell, N. Petro, and D.E. Ellis Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study Kidney Int. 62 2002 963 970
30. M.E. Pagtalunan, P.L. Miller, S. Jumping-Eagle, R.G. Nelson, B.D. Myers, H.G. Rennke, N.S. Coplon, L. Sun, and T.W. Meyer Podocyte loss and progressive glomerular injury in type II diabetes J. Clin. Invest. 99 1997 342 348
31. U. Panchapakesan, X.M. Chen, and C.A. Pollock Drug insight: thiazolidinediones and diabetic nephropathy - relevance to renoprotection Nat. Clin. Pract. Nephrol. 1 2005 33 43
32. S. Patel, B.W. Doble, K. MacAulay, E.M. Sinclair, D.J. Drucker, and J.R. Woodgett Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action Mol. Cell. Biol. 28 2008 6314 6328
33. H. Pavenstädt, W. Kriz, and M. Kretzler Cell biology of the glomerular podocyte Physiol. Rev. 83 2003 253 307
34. V. Perkovic, C. Verdon, T. Ninomiya, F. Barzi, A. Cass, A. Patel, M. Jardine, M. Gallagher, F. Turnbull, and J. Chalmers The relationship between proteinuria and coronary risk: a systematic review and meta-analysis PLoS Med. 5 2008 e207
35. F.R. Postma, K. Jalink, T. Hengeveld, and W.H. Moolenaar Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor EMBO J. 15 1996 2388 2392
36. M.A. Potenza, F. Addabbo, and M. Montagnani Vascular actions of insulin with implications for endothelial dysfunction Am. J. Physiol. Endocrinol. Metab. 297 2009 E568 E577
37. E. Rinderknecht, and R.E. Humbel The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin J. Biol. Chem. 253 1978 2769 2776
38. M.A. Saleem, M.J. O'Hare, J. Reiser, R.J. Coward, C.D. Inward, T. Farren, C.Y. Xing, L. Ni, P.W. Mathieson, and P. Mundel A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression J. Am. Soc. Nephrol. 13 2002 630 638
39. S.C. Satchell, C.H. Tasman, A. Singh, L. Ni, J. Geelen, C.J. von Ruhland, M.J. O'Hare, M.A. Saleem, L.P. van den Heuvel, and P.W. Mathieson Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF Kidney Int. 69 2006 1633 1640
40. S.C. Satchell, O. Buchatska, S.B. Khan, G. Bhangal, C.H. Tasman, M.A. Saleem, D.P. Baker, R.R. Lobb, J. Smith, and H.T. Cook Interferon-beta reduces proteinuria in experimental glomerulonephritis J. Am. Soc. Nephrol. 18 2007 2875 2884
41. P.R. Shepherd, and B.B. Kahn Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus N. Engl. J. Med. 341 1999 248 257
42. J. Tamayo, A.D. Humphris, R.J. Owen, and M.J. Miles High-Q dynamic force microscopy in liquid and its application to living cells Biophys. J. 81 2001 526 537
43. T. Tejada, P. Catanuto, A. Ijaz, J.V. Santos, X. Xia, P. Sanchez, N. Sanabria, O. Lenz, S.J. Elliot, and A. Fornoni Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death Kidney Int. 73 2008 1385 1393
44. B. Vollenbröker, B. George, M. Wolfgart, M.A. Saleem, H. Pavenstädt, and T. Weide mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes Am. J. Physiol. Renal Physiol. 296 2009 F418 F426
45. J.H. Wijsman, R.R. Jonker, R. Keijzer, C.J. van de Velde, C.J. Cornelisse, and J.H. van Dierendonck A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA J. Histochem. Cytochem. 41 1993 7 12
46. G. Wolf, and F.N. Ziyadeh Molecular mechanisms of diabetic renal hypertrophy Kidney Int. 56 1999 393 405 (Pubitemid 29353136)
47. G. Wolf, S. Chen, and F.N. Ziyadeh From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy Diabetes 54 2005 1626 1634
48. H. Yki-Järvinen, and V.A. Koivisto Natural course of insulin resistance in type I diabetes N. Engl. J. Med. 315 1986 224 230
49. H. Zhang, A.V. Cybulsky, L. Aoudjit, J. Zhu, H. Li, N. Lamarche-Vane, and T. Takano Role of Rho-GTPases in complement-mediated glomerular epithelial cell injury Am. J. Physiol. Renal Physiol. 293 2007 F148 F156
50. H. Zhang, J. Saha, J. Byun, M. Schin, M. Lorenz, R.T. Kennedy, M. Kretzler, E.L. Feldman, S. Pennathur, and F.C. Brosius 3rd Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy Am. J. Physiol. Renal Physiol. 295 2008 F1071 F1081
51. P. Zimmet, K.G. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787